---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-019834"
form_type: "8-K"
ticker: "CHRN"
cik: "0001549084"
company_name: "EKSO BIONICS HOLDINGS, INC."
filed_at: "2024-06-10T23:59:59+00:00"
generated_at: "2026-06-01T05:17:34.826009+00:00"
event_type: "other"
sentiment: "positive"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Ekso Bionics shareholders approve all proposals at 2024 annual meeting

## Summary
- All five director nominees elected: Scott Davis, Mary Ann Cloyd, Corinna Lathan, Charles Li, Deborah Lafer Scher.
- Equity incentive plan extended to April 2034; authorized shares increased to 4,724,286 (1M increase).
- Advisory say-on-pay approved: 6,303,399 for, 631,663 against, 124,065 abstained.
- Annual frequency for future advisory votes selected: 6,840,255 for 1 year.
- WithumSmith+Brown ratified as auditor for FY2024: 11,245,624 for, 153,991 against.

## SEC filing metadata
- accession: 0001437749-24-019834
- form_type: 8-K
- ticker: CHRN
- cik: 0001549084
- company_name: EKSO BIONICS HOLDINGS, INC.
- filed_at: 2024-06-10T23:59:59+00:00
- event_type: other
- sentiment: positive
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549084/000143774924019834/0001437749-24-019834-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549084/000143774924019834/ekso20240610_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-019834
- JSON: https://secwatch.observer/filing/0001437749-24-019834.json
- Plain text: https://secwatch.observer/filing/0001437749-24-019834.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.